We are pleased to announce today that Chambers USA ranked Milligan Lawless, P.C. and 4 of our attorneys among the best in Arizona for 2026. Milligan Lawless was ranked for both its corporate and mergers and acquisitions practice and its healthcare practice. Chambers USA is an annual ranking that assesses each law firm and attorney…
By: Ian M. Stanford and Steven T. Lawrence Artificial intelligence (AI) is becoming increasingly embedded in business operations across all industries. A McKinsey survey in late 2025 found that 88 percent of companies reported using AI in at least one business function.[1] AI poses unique risks for companies that contract with supply chain or information…
By: Aaron E. Kacer and Steven T. Lawrence On March 30, 2026, the U.S. Treasury and the Financial Crimes Enforcement Network (FinCEN) announced a new coordinated policy aimed at fraud schemes that intend to exploit Medicare, Medicaid, and other federal and state healthcare benefit programs.[1] The new policy includes (i) FinCEN advisory describing common healthcare…
Physician groups are frequently approached with “business opportunities” that sound routine, such as equipment leases, administrative services agreements, space rentals, and networking events. But all too often, those offers are really just dressed-up referral schemes that can land physicians in trouble. Two recent federal cases are important reminders that when it comes to vendor relationships,…
By: Desalina A. Williams and Jodi R. Bohr Every employer in the United States is required by federal law to properly complete a Form I-9: Employment Eligibility Verification (commonly referred to as “Form I-9”) for each employee.[1] To satisfy this requirement, employers must: Use the current, unexpired Form I-9. At the time of publication, the…
CORPORATE TRANSPARENCY ACT UPDATE As we near the end of the first quarter of 2026, the CTA continues to generate confusion. Over the past year, business news headlines were flooded with the CTA articles at a rapid pace – from “CTA Reinstatement” to “CTA Enjoined,” “CTA Suspended,” and “New Interim Final Rule” – as a…
The materials provided in this website are for informational purposes only and are not for the purpose of providing legal advice. Transmission of information from the ML website is not intended to create, and its receipt by you does not create an attorney-client relationship with ML or any of its individual attorneys or personnel.
If you elect to communicate with anyone at ML through this website, or otherwise, in connection with a matter for which we do not already represent you, your communication can not be treated as privileged or confidential. Do not transmit any information about any matter (and particularly not information you regard as confidential) that may involve you until ML has agreed to represent you, and you have received confirmation of that fact in the form of a written engagement letter.